At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof Marek Trn?ný (Charles University Hospital, Prague, Czech Republic) discuss recent advances in the management of patients with mantle cell lymphoma, including maintenance treatment and the development of personalised medicine.
Part 1: http://www.oncologytube.com/v/1034690/ash-2014-prof-john-gribben-and-prof-marek-trn-n-discuss-recent-advances-in-mantle-cell-lymphoma-treatment
Part 2: http://www.oncologytube.com/v/1034691/ash-2014-prof-john-gribben-and-prof-marek-trn-n-discuss-recent-advances-in-mantle-cell-lymphoma-treatment
This programme has been supported by sponsorship from Celgene
European Medical Journal
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews